Literature DB >> 21945472

Role of phosphorylation in progesterone receptor signaling and specificity.

Christy R Hagan1, Andrea R Daniel, Gwen E Dressing, Carol A Lange.   

Abstract

Progesterone receptors (PR), in concert with peptide growth factor-initiated signaling pathways, initiate massive expansion of the epithelial cell compartment associated with the process of alveologenesis in the developing mammary gland. PR-dependent signaling events also contribute to inappropriate proliferation observed in breast cancer. Notably, PR-B isoform-specific cross talk with growth factor-driven pathways is required for the proliferative actions of progesterone. Indeed, PRs act as heavily phosphorylated transcription factor "sensors" for mitogenic protein kinases that are often elevated and/or constitutively activated in invasive breast cancers. In addition, phospho-PR-target genes frequently include the components of mitogenic signaling pathways, revealing a mechanism for feed-forward signaling that confers increased responsiveness of, PR +mammary epithelial cells to these same mitogenic stimuli. Understanding the mechanisms and isoform selectivity of PR/kinase interactions may yield further insight into targeting altered signaling networks in breast and other hormonally responsive cancers (i.e. lung, uterine and ovarian) in the clinic. This review focuses on PR phosphorylation by mitogenic protein kinases and mechanisms of PR-target gene selection that lead to increased cell proliferation.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21945472      PMCID: PMC3265648          DOI: 10.1016/j.mce.2011.09.017

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  75 in total

Review 1.  Role of the CDK inhibitor p27 (Kip1) in mammary development and carcinogenesis: insights from knockout mice.

Authors:  Elizabeth A Musgrove; Elizabeth A Davison; Christopher J Ormandy
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-01       Impact factor: 2.673

Review 2.  p27 deregulation in breast cancer: prognostic significance and implications for therapy.

Authors:  A Alkarain; R Jordan; J Slingerland
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-01       Impact factor: 2.673

3.  Mutational analysis of progesterone receptor functional domains in stable cell lines delineates sets of genes regulated by different mechanisms.

Authors:  Ignacio Quiles; Lluís Millán-Ariño; Alicia Subtil-Rodríguez; Belén Miñana; Nora Spinedi; Cecilia Ballaré; Miguel Beato; Albert Jordan
Journal:  Mol Endocrinol       Date:  2009-03-19

4.  Epidermal growth factor increases coactivation of the androgen receptor in recurrent prostate cancer.

Authors:  Christopher W Gregory; Xiaoyin Fei; Liliana A Ponguta; Bin He; Heather M Bill; Frank S French; Elizabeth M Wilson
Journal:  J Biol Chem       Date:  2003-12-08       Impact factor: 5.157

Review 5.  Expression profiling of human breast cancers and gene regulation by progesterone receptors.

Authors:  Britta M Jacobsen; Jennifer K Richer; Carol A Sartorius; Kathryn B Horwitz
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-07       Impact factor: 2.673

Review 6.  Protein kinase CK2 in health and disease: CK2: a key player in cancer biology.

Authors:  J H Trembley; G Wang; G Unger; J Slaton; K Ahmed
Journal:  Cell Mol Life Sci       Date:  2009-06       Impact factor: 9.261

7.  Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform.

Authors:  Biserka Mulac-Jericevic; John P Lydon; Francesco J DeMayo; Orla M Conneely
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-01       Impact factor: 11.205

Review 8.  MAP kinases couple multiple functions of human progesterone receptors: degradation, transcriptional synergy, and nuclear association.

Authors:  Ming Qiu; Carol A Lange
Journal:  J Steroid Biochem Mol Biol       Date:  2003-06       Impact factor: 4.292

Review 9.  Integrated actions of progesterone receptor and cell cycle machinery regulate breast cancer cell proliferation.

Authors:  Gwen E Dressing; Carol A Lange
Journal:  Steroids       Date:  2008-12-11       Impact factor: 2.668

Review 10.  Signaling inputs to progesterone receptor gene regulation and promoter selectivity.

Authors:  Andrea R Daniel; Todd P Knutson; Carol A Lange
Journal:  Mol Cell Endocrinol       Date:  2009-01-20       Impact factor: 4.102

View more
  36 in total

1.  The Flavonoid Apigenin Is a Progesterone Receptor Modulator with In Vivo Activity in the Uterus.

Authors:  Matthew Dean; Julia Austin; Ren Jinhong; Michael E Johnson; Daniel D Lantvit; Joanna E Burdette
Journal:  Horm Cancer       Date:  2018-05-07       Impact factor: 3.869

2.  Progesterone Receptor Attenuates STAT1-Mediated IFN Signaling in Breast Cancer.

Authors:  Merit L Goodman; Gloria M Trinca; Katherine R Walter; Evangelia K Papachristou; Clive S D'Santos; Tianbao Li; Qi Liu; Zhao Lai; Prabhakar Chalise; Rashna Madan; Fang Fan; Mary A Markiewicz; Victor X Jin; Jason S Carroll; Christy R Hagan
Journal:  J Immunol       Date:  2019-04-01       Impact factor: 5.422

Review 3.  Neural progestin receptors and female sexual behavior.

Authors:  Shaila K Mani; Jeffrey D Blaustein
Journal:  Neuroendocrinology       Date:  2012-09-14       Impact factor: 4.914

Review 4.  Progesterone action in breast, uterine, and ovarian cancers.

Authors:  Caroline H Diep; Andrea R Daniel; Laura J Mauro; Todd P Knutson; Carol A Lange
Journal:  J Mol Endocrinol       Date:  2015-01-13       Impact factor: 5.098

Review 5.  Progesterone receptors (PR) mediate STAT actions: PR and prolactin receptor signaling crosstalk in breast cancer models.

Authors:  Katherine A Leehy; Thu H Truong; Laura J Mauro; Carol A Lange
Journal:  J Steroid Biochem Mol Biol       Date:  2017-04-23       Impact factor: 4.292

6.  Irilone from Red Clover ( Trifolium pratense) Potentiates Progesterone Signaling.

Authors:  Jung-Ho Lee; Matthew Dean; Julia R Austin; Joanna E Burdette; Brian T Murphy
Journal:  J Nat Prod       Date:  2018-09-10       Impact factor: 4.050

Review 7.  Post-translational modifications of the progesterone receptors.

Authors:  Hany A Abdel-Hafiz; Kathryn B Horwitz
Journal:  J Steroid Biochem Mol Biol       Date:  2013-12-12       Impact factor: 4.292

Review 8.  Deciphering the divergent roles of progestogens in breast cancer.

Authors:  Jason S Carroll; Theresa E Hickey; Gerard A Tarulli; Michael Williams; Wayne D Tilley
Journal:  Nat Rev Cancer       Date:  2016-11-25       Impact factor: 60.716

9.  The requirement for p42/p44 MAPK activity in progesterone receptor-mediated gene regulation is target gene-specific.

Authors:  Lindsey S Treviño; William E Bingman; Dean P Edwards; Weigel Nl
Journal:  Steroids       Date:  2013-02-01       Impact factor: 2.668

Review 10.  Tracking progesterone receptor-mediated actions in breast cancer.

Authors:  Todd P Knutson; Carol A Lange
Journal:  Pharmacol Ther       Date:  2013-11-26       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.